Ascendis has narrowed its annual loss for continuing operations as it cut down its debt and restructured, but the healthcare group is hoping to leave the JSE and go private within the next financial year.

“There is value to unlock for shareholders in this group, but the value will not firstly be unlocked in a JSE-listed environment,” CEO Carl Neethling said on Friday in the results presentation. “The quickest and easiest path for a value unlock for shareholders that want to stay the course would be to support delisting.”..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.